Swedish Orphan Biovitrum (Sobi) (SOBI.ST)

Quick facts

Marketed products

• Vonjo · Oncology
  Vonjo works by blocking the activity of the JAK2 enzyme, which is overactive in myelofibrosis patients.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Swedish Orphan Biovitrum (Sobi) portfolio CI brief
• Swedish Orphan Biovitrum (Sobi) pipeline updates RSS